PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $20,095,442,000 | +100593.7% | 3,948,024 | 0.0% | 0.13% | -3.6% |
| Q3 2019 | $19,957,000 | -18.1% | 3,948,024 | 0.0% | 0.14% | -16.8% |
| Q2 2019 | $24,359,000 | +33.0% | 3,948,024 | 0.0% | 0.17% | +28.5% |
| Q1 2019 | $18,318,000 | +10.5% | 3,948,024 | 0.0% | 0.13% | -7.1% |
| Q4 2018 | $16,582,000 | -33.0% | 3,948,024 | 0.0% | 0.14% | -20.9% |
| Q3 2018 | $24,745,000 | -22.0% | 3,948,024 | 0.0% | 0.18% | -29.2% |
| Q2 2018 | $31,742,000 | +13.1% | 3,948,024 | 0.0% | 0.25% | +14.7% |
| Q1 2018 | $28,070,000 | +28.8% | 3,948,024 | +7.8% | 0.22% | -6.0% |
| Q4 2017 | $21,790,000 | – | 3,662,118 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 17,902,338 | $135,342,000 | 5.88% |
| TIGER MANAGEMENT L.L.C. | 1,288,454 | $9,741,000 | 1.91% |
| Phocas Financial Corp. | 1,047,181 | $7,917,000 | 0.69% |
| TUDOR INVESTMENT CORP ET AL | 2,370,503 | $17,921,000 | 0.62% |
| EAM Investors, LLC | 553,309 | $4,183,000 | 0.58% |
| Baker Brothers Advisors | 4,449,797 | $33,640,000 | 0.34% |
| TFS CAPITAL LLC | 463,740 | $3,506,000 | 0.33% |
| FEDERATED HERMES, INC. | 13,508,290 | $102,123,000 | 0.32% |
| Rotella Capital Management, Inc. | 36,473 | $276,000 | 0.24% |
| OXFORD ASSET MANAGEMENT LLP | 1,103,848 | $8,351,000 | 0.18% |